IB-367, a Protegrin Peptide with In Vitro and In Vivo Activities against the Microflora Associated with Oral Mucositis

• Published in: Antimicrobial Agents and Chemotherapy Vol. 44; no. 7; pp. 1803 - 1808
• Main Authors: Mosca, Deborah A., Hurst, Malinda A., So, Wendy, Viajar, Beverly S. C., Fujii, Craig A., Falla, Timothy J.
• Format: Journal Article
• Language: English
• Published: Washington, DC American Society for Microbiology 01.07.2000
• Subjects: Anti-Bacterial Agents; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Antibacterial agents; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antimicrobial Cationic Peptides; Biological and medical sciences; Drug Resistance, Microbial - physiology; Escherichia; Escherichia - drug effects; Escherichia - physiology; Humans; Klebsiella; Klebsiella - drug effects; Klebsiella - physiology; Medical sciences; Microbial Sensitivity Tests; Mouth Diseases; Mouth Diseases - drug therapy; Mouth Diseases - microbiology; Mouth Mucosa - drug effects; Mouth Mucosa - microbiology; Mouth Mucosa - pathology; Peptides - pharmacology; Pharmacology. Drug treatments; Protegrin peptide; Proteins; Proteins - pharmacology; Proteins - therapeutic use; Pseudomonas; Saliva - microbiology; Staphylococcus aureus; Streptococcus; Streptococcus - drug effects; Streptococcus - physiology; Streptococcus mitis; Streptococcus salivarius; Streptococcus sanguis; Susceptibility; Human; Healthy subject; Peptides; Oral administration; Microflora; In vitro; Biological activity; Antimicrobial agent; Fungi; Prevention; Oral cavity; In vivo; Antibiotic; Antifungal agent; Chemotherapy; Sensitivity resistance; Bacteria; Oral cavity disease; Antibacterial agent; Thallophyta

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...